You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 1, January 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  This Month in Archives of Dermatology
 This Article
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

This Month in Archives of Dermatology

Arch Dermatol. 2002;138:15.

Treatment of Scleroderma

Systemic sclerosis (scleroderma) affects many organ systems, and skin findings are often the most immediately visible. Treating systemic sclerosis remains an immense clinical challenge. Sapadin and Fleischmajer critically analyze the conventional as well as the new therapeutic approaches to this condition that are directed toward improving circulation, preventing the synthesis and release of harmful cytokines, and inhibiting or reducing fibrosis.

(SEE ARTICLE)


Amyopathic Dermatomyositis: A Review by the Italian Group of Immunodermatology

Dermatomyositis is a relatively rare connective tissue disease that often presents with characteristic dermatologic findings. In the absence of inflammatory myopathy, patients are considered to have amyopathic dermatomyositis. In this retrospective analysis of 13 such patients, the clinical features and serum immunologic findings support an overall favorable prognosis.

(SEE ARTICLE)


Concordance Between Telepathologic Diagnosis and Conventional Histopathologic Diagnosis: A Multiobserver, Store-and-Forward Study on 20 Skin Specimens

Telepathology may be defined as the practice of pathology at a distance. This is most often accomplished by visualizing an electronically transmitted digital image on a monitor instead of viewing the specimen directly through a microscope. In this study using 20 skin biopsy specimens, Piccolo et al demonstrate concordance between diagnoses made after conventional glass slide evaluation and those rendered after evaluation of digital images.

(SEE ARTICLE)


Efficacy of Itraconazole in the Prophylactic Treatment of Pityriasis (Tinea) Versicolor

Tinea versicolor may be successfully treated with a variety of topical or systemic medications; however, recurrence rates are unfortunately quite high. Faergemann et al demonstrate that prophylactic therapy with 400 mg of itraconazole once monthly is an effective and safe maintenance or prophylactic regimen to prevent these recurrences.

(SEE ARTICLE)


The Combined Continuous-Wave/Pulsed Carbon Dioxide Laser for Treatment of Pyogenic Granuloma

Pyogenic granuloma is a common, benign vascular tumor. Various treatment methods have been described, including excision, curettage, cryotherapy, chemical and electrical cauterization, and a variety of laser techniques. In this prospective study, Raulin et al demonstrate the safety and efficacy of the combined use of the continuous-wave and pulsed carbon dioxide lasers for treating pyogenic granuloma.


A, Patient with pyogenic granuloma on the lower lip. B, Same patient 7 weeks after a single therapy session with the continuous-wave/pulsed carbon dioxide laser. The lesion has healed completely with only slight textural changes.


(SEE ARTICLE)


Melanocytic Proliferations Associated With Lichen Sclerosus

Lichen sclerosus (LS) is a chronic inflammatory dermatosis that may cause intractable itching and destructive scarring. The classic lesions of LS have a white, depigmented, or vitiligolike appearance, although pigmentation is present on rare occasions. Melanocytic nevi may be superimposed on lesions of LS, and melanoma may even arise in the background of LS. Carlson et al describe the key histologic features that can be used to confidently separate LS melanocytic nevi from malignant melanoma.

(SEE ARTICLE)



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.